Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gw5074 (1 trial)
sorafenib (nexavar) (1 trial)
mg-s-2525 (1 trial)
Idiopathic Pulmonary Fibrosis (Phase 1)
Neoplasms (Phase 2)
Pulmonary Fibrosis (Phase 1)
Trials (2 total)
Trial APIs (3 total)